Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
A First-in-Human Study Using BDC-4182 as a Single Agent in Advanced Gastric and Gastroesophageal CancerDigestive System Diseases, Digestive System Neoplasms, Neoplasms by Site, digestive system disorder, digestive system neoplasm, gastric neoplasm, gastroesophageal adenocarcinoma, neoplasm, stomach disorderRecruitingPhase 1 / Phase 22026-01-27NCT06921837

1 results · Page 1 of 1

Swipe the table sideways for more columns.

OrganizationsLinked trials
Bolt Biotherapeutics, Inc.1

16 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
AUS Site 1BirtinyaAustralia1
AUS Site 2DarlinghurstAustralia1
AUS Site 3HeidelbergAustralia1
AUS Site 4ClaytonAustralia1
AUS Site 5WestmeadAustralia1
SK Site 2001SeoulSouth Korea1
SK Site 2002SeoulSouth Korea1
SK Site 2003Seongnam-siSouth Korea1
SK Site 2004SeoulSouth Korea1
SK Site 2005SeoulSouth Korea1
TWN Site 9001TaichungTaiwan1
TWN Site 9002TaoyuanTaiwan1
TWN Site 9003TaipeiTaiwan1
TWN Site 9004Kaohsiung CityTaiwan1
TWN Site 9005Kaohsiung CityTaiwan1
TWN Site 9006TaipeiTaiwan1